CN Patent

CN102036656A — 含有蜡的缓释制剂

Assigned to Mylan Pharmaceuticals Inc · Expires 2011-04-27 · 15y expired

What this patent protects

本发明公开缓释药物制剂，其中所述制剂包含缓释部分和速释部分，所述缓释部分包含活性药物成分和蜡。本发明还公开制备这样的缓释药物制剂的方法。

USPTO Abstract

本发明公开缓释药物制剂，其中所述制剂包含缓释部分和速释部分，所述缓释部分包含活性药物成分和蜡。本发明还公开制备这样的缓释药物制剂的方法。

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: CN102036656A
Jurisdiction: CN
Classification: —
Expires: 2011-04-27
Drug substance claim: No
Drug product claim: No
Assignee: Mylan Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.